ÂÜÀòÂÒÂ×

The Board of Directors at Synklino provides strategic guidance, oversight, and governance to ensure that the company remains focused on its mission to develop a CMV-specific immunotoxin. They supervise executive management, make high-level policy decisions, and ensure financial and regulatory compliance to drive the company toward sustainable growth and success.